Nemaura Medical Inc. (NMRD) financial statements (2022 and earlier)

Company profile

Business Address 57 WEST 57TH STREET
MANHATTAN, NY 10019
State of Incorp.
Fiscal Year End March 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
TTM
3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments23,04631,8651063,7418229119,404
Cash and cash equivalents23,04631,8651063,7418229119,404
Receivables153      
Inventory, net of allowances, customer advances and progress billings1,38485128638   
Inventory1,38485128638   
Prepaid expense 593352    
Other undisclosed current assets4726771017365,1761,919148
Total current assets:25,05633,9868454,5155,9992,8309,552
Noncurrent Assets
Property, plant and equipment      8
Intangible assets, net (including goodwill)      173
Intangible assets, net (excluding goodwill)      173
Other noncurrent assets2,0181,257375249257213 
Other undisclosed noncurrent assets     4,359 
Total noncurrent assets:2,0181,2573752492574,572181
TOTAL ASSETS:27,07435,2431,2204,7646,2557,4029,733
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities177254294161507873
Accounts payable177254294161507873
Deferred revenue46310393
Debt14,8515,733     
Due to related parties 14983096561468891
Other liabilities64518116910814887494
Other undisclosed current liabilities   65   
Total current liabilities:16,1356,4201,3861,299811852658
Noncurrent Liabilities
Long-term debt and lease obligation8,71319,189     
Long-term debt, excluding current maturities8,71319,189     
Liabilities, other than long-term debt328   1,3331,1831,396
Deferred revenue and credits1,3331,1831,396
Deferred revenue328  
Other undisclosed noncurrent liabilities8741,2761,1471,238   
Total noncurrent liabilities:9,91520,4651,1471,2381,3331,1831,396
Total liabilities:26,05026,8852,5332,5372,1442,0352,054
Stockholders' equity
Stockholders' equity attributable to parent, including:1,0248,358(1,313)2,2274,1115,367769
Preferred stock    0  
Common stock23232120868205205
Additional paid in capital35,12232,04416,58915,78513,05712,92012,920
Accumulated other comprehensive income (loss)(7)136(337)(340)(41)(606)155
Accumulated deficit(34,114)(23,845)(17,586)(13,426)(8,973)(7,153)(5,601)
Other undisclosed stockholders' equity attributable to parent      (6,910)
Other undisclosed stockholders' equity      6,910
Total stockholders' equity:1,0248,358(1,313)2,2274,1115,3677,679
TOTAL LIABILITIES AND EQUITY:27,07435,2431,2204,7646,2557,4029,733

Income statement (P&L) ($ in thousands)

12/31/2021
TTM
3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
Revenues180 42489  
Net investment income  42489  
Cost of revenue
(Cost of Goods and Services Sold)
(172)      
Gross profit:11 42489  
Operating expenses(4,579)(4,587)(4,778)(4,477)(1,909)(1,551)(1,540)
Other undisclosed operating loss  (4)(24)(89)  
Operating loss:(4,568)(4,587)(4,778)(4,477)(1,909)(1,551)(1,540)
Nonoperating income (expense)
(Foreign Currency Transaction Gain (Loss), before Tax)
   2699(994)47
Loss from continuing operations before equity method investments, income taxes:(4,568)(4,587)(4,778)(4,451)(1,810)(2,545)(1,493)
Other undisclosed income (loss) from continuing operations before income taxes(2,008)(2,008)4(2)(10)994(47)
Loss from continuing operations before income taxes:(6,576)(6,594)(4,775)(4,453)(1,820)(1,551)(1,540)
Income tax expense (benefit)(279)336614    
Loss before gain (loss) on sale of properties:(6,854)(6,259)(4,160)(4,453)(1,820)(1,551)(1,540)
Other undisclosed net loss(1,639)      
Net loss:(8,494)(6,259)(4,160)(4,453)(1,820)(1,551)(1,540)
Other undisclosed net loss attributable to parent(5,221)      
Net loss available to common stockholders, diluted:(13,715)(6,259)(4,160)(4,453)(1,820)(1,551)(1,540)

Comprehensive Income ($ in thousands)

12/31/2021
TTM
3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
Net loss:(8,494)(6,259)(4,160)(4,453)(1,820)(1,551)(1,540)
Other comprehensive income (loss)   (299)565(761)136
Comprehensive loss:(8,494)(6,259)(4,160)(4,752)(1,256)(2,312)(1,404)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1,241)4733    
Comprehensive loss, net of tax, attributable to parent:(9,735)(5,786)(4,157)(4,752)(1,256)(2,312)(1,404)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: